دورية أكاديمية
أعرض في EDS

Implications of Post-recanalization Perfusion Deficit After Acute Ischemic Stroke: a Scoping Review of Clinical and Preclinical Imaging Studies.

التفاصيل البيبلوغرافية
العنوان: Implications of Post-recanalization Perfusion Deficit After Acute Ischemic Stroke: a Scoping Review of Clinical and Preclinical Imaging Studies.
المؤلفون: van der Knaap N; Biomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands., Franx BAA; Biomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands. a.a.franx@umcutrecht.nl., Majoie CBLM; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Location University of Amsterdam, Amsterdam, The Netherlands., van der Lugt A; Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands., Dijkhuizen RM; Biomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands. r.m.dijkhuizen@umcutrecht.nl.
مؤلفون مشاركون: CONTRAST consortium
المصدر: Translational stroke research [Transl Stroke Res] 2024 Feb; Vol. 15 (1), pp. 179-194. Date of Electronic Publication: 2023 Jan 19.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 101517297 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1868-601X (Electronic) Linking ISSN: 18684483 NLM ISO Abbreviation: Transl Stroke Res Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York : Springer
مواضيع طبية MeSH: Brain Ischemia*/diagnostic imaging , Brain Ischemia*/therapy , Brain Ischemia*/complications , Ischemic Stroke*/diagnostic imaging , Ischemic Stroke*/complications , Stroke*/diagnostic imaging , Stroke*/therapy , Stroke*/etiology, Animals ; Humans ; Ischemia/complications ; Reperfusion/methods ; Treatment Outcome ; Cerebrovascular Circulation/physiology
مستخلص: The goal of reperfusion therapy for acute ischemic stroke (AIS) is to restore cerebral blood flow through recanalization of the occluded vessel. Unfortunately, successful recanalization does not always result in favorable clinical outcome. Post-recanalization perfusion deficits (PRPDs), constituted by cerebral hypo- or hyperperfusion, may contribute to lagging patient recovery rates, but its clinical significance remains unclear. This scoping review provides an overview of clinical and preclinical findings on post-ischemic reperfusion, aiming to elucidate the pattern and consequences of PRPD from a translational perspective. The MEDLINE database was searched for quantitative clinical and preclinical studies of AIS reporting PRPD based on cerebral circulation parameters acquired by translational tomographic imaging methods. PRPD and stroke outcome were mapped on a charting table, creating an overview of PRPD after AIS. Twenty-two clinical and twenty-two preclinical studies were included. Post-recanalization hypoperfusion is rarely reported in clinical studies (4/22) but unequivocally associated with detrimental outcome. Post-recanalization hyperperfusion is more commonly reported (18/22 clinical studies) and may be associated with positive or negative outcome. PRPD has been replicated in animal studies, offering mechanistic insights into causes and consequences of PRPD and allowing delineation of possible courses of PRPD. Complex relationships exist between PRPD and stroke outcome. Diversity in methods and lack of standardized definitions in reperfusion studies complicate the characterization of reperfusion patterns. Recommendations are made to advance the understanding of PRPD mechanisms and to further disentangle the relation between PRPD and disease outcome.
(© 2023. The Author(s).)
References: Neurology. 2000 Feb 8;54(3):689-96. (PMID: 10680805)
Stroke. 2003 Jun;34(6):1425-30. (PMID: 12738899)
Front Neurol. 2017 Jan 12;7:245. (PMID: 28127292)
Ann Neurol. 2017 Jun;81(6):849-856. (PMID: 28486789)
Res Synth Methods. 2014 Dec;5(4):371-85. (PMID: 26052958)
Ann Neurol. 2000 Aug;48(2):236-44. (PMID: 10939575)
Stroke. 2018 Nov;49(11):2643-2651. (PMID: 30355192)
J Cereb Blood Flow Metab. 2017 Sep;37(9):3087-3090. (PMID: 28665168)
J Cereb Blood Flow Metab. 2021 Aug;41(8):2067-2075. (PMID: 33557694)
Stroke. 2018 Sep;49(9):2102-2107. (PMID: 30354992)
J Cereb Blood Flow Metab. 1999 May;19(5):467-82. (PMID: 10326714)
Curr Pain Headache Rep. 2018 Mar 19;22(4):24. (PMID: 29556806)
J Cereb Blood Flow Metab. 1997 Apr;17(4):388-400. (PMID: 9143221)
Neurology. 2001 Dec 11;57(11):2015-21. (PMID: 11739819)
J Cereb Blood Flow Metab. 2011 Jun;31(6):1403-11. (PMID: 21179070)
Stroke. 2013 Mar;44(3):681-5. (PMID: 23390119)
Neuroscience. 2014 Jun 6;269:223-31. (PMID: 24680939)
J Neuroimaging. 2019 Mar;29(2):193-197. (PMID: 30302863)
J Cereb Blood Flow Metab. 1997 May;17(5):553-9. (PMID: 9183293)
J Cereb Blood Flow Metab. 2002 Mar;22(3):253-61. (PMID: 11891430)
J Cereb Blood Flow Metab. 2011 Oct;31(10):2076-85. (PMID: 21540871)
Front Neurol. 2021 Jan 21;11:594613. (PMID: 33551955)
Stroke. 2013 Jul;44(7):1872-7. (PMID: 23743977)
J Cereb Blood Flow Metab. 2017 Mar;37(3):1148-1162. (PMID: 27256323)
J Neurol Neurosurg Psychiatry. 1996 Jul;61(1):26-9. (PMID: 8676153)
Stroke. 1995 Apr;26(4):627-34; discussion 635. (PMID: 7709410)
J Neurosurg. 1981 Jun;54(6):773-82. (PMID: 7241187)
J Cereb Blood Flow Metab. 2016 Feb;36(2):363-9. (PMID: 26661175)
NeuroRx. 2005 Jul;2(3):396-409. (PMID: 16389304)
Stroke. 2018 Aug;49(8):1969-1976. (PMID: 29991657)
AJNR Am J Neuroradiol. 2004 Sep;25(8):1342-7. (PMID: 15466329)
Eur Neurol. 2010;64(5):286-96. (PMID: 20980761)
J Neurointerv Surg. 2022 Jan;14(1):. (PMID: 33762405)
Lancet. 1993 Apr 10;341(8850):925-7. (PMID: 8096267)
Neuroscience. 2012 Jun 28;213:47-53. (PMID: 22521831)
J Cereb Blood Flow Metab. 2012 Dec;32(12):2091-9. (PMID: 23047270)
J Cereb Blood Flow Metab. 2017 Aug;37(8):2706-2715. (PMID: 27742887)
J Cereb Blood Flow Metab. 2021 Feb;41(2):236-252. (PMID: 32237951)
Stroke. 2007 Apr;38(4):1336-44. (PMID: 17322082)
Int J Stroke. 2015 Feb;10(2):143-52. (PMID: 25598025)
AJNR Am J Neuroradiol. 2020 Jan;41(1):79-85. (PMID: 31857324)
Crit Care Med. 2020 Nov;48(11):1654-1663. (PMID: 32947473)
J Cereb Blood Flow Metab. 2015 Mar 31;35(4):630-7. (PMID: 25564233)
Anesthesiology. 2017 Apr;126(4):653-665. (PMID: 28182585)
Neuroradiology. 2007 Feb;49(2):93-102. (PMID: 17177065)
Stroke. 2020 Jun;51(6):1736-1742. (PMID: 32404034)
Neurology. 2008 Nov 25;71(22):1804-11. (PMID: 19029520)
Transl Stroke Res. 2018 Feb;9(1):44-50. (PMID: 28825223)
Transl Stroke Res. 2021 Oct;12(5):799-807. (PMID: 33432454)
Cerebrovasc Dis. 2005;19(2):117-24. (PMID: 15640606)
Front Neurol. 2017 Oct 13;8:539. (PMID: 29081762)
Dis Model Mech. 2012 Nov;5(6):718-25. (PMID: 23115201)
Eur J Vasc Endovasc Surg. 2018 Sep;56(3):322-333. (PMID: 30196814)
Stroke. 2009 Feb;40(2):469-75. (PMID: 19109547)
Stroke. 2019 Oct;50(10):2960-2963. (PMID: 31535931)
Lancet. 2007 Jan 27;369(9558):293-8. (PMID: 17258669)
PLoS One. 2013 May 31;8(5):e65322. (PMID: 23741488)
J Cereb Blood Flow Metab. 2021 Apr;41(4):731-744. (PMID: 32703056)
J Cereb Blood Flow Metab. 2022 Mar;42(3):387-403. (PMID: 34259070)
Ann Intern Med. 2018 Oct 2;169(7):467-473. (PMID: 30178033)
Stroke. 2002 Dec;33(12):2985-91. (PMID: 12468801)
Brain. 1996 Apr;119 ( Pt 2):409-19. (PMID: 8800936)
J Cereb Blood Flow Metab. 2019 Nov;39(11):2277-2285. (PMID: 30117360)
Stroke. 2019 Sep;50(9):2389-2395. (PMID: 31366315)
Int J Stroke. 2019 Dec;14(9):946-955. (PMID: 31132969)
Cell Rep. 2020 Oct 13;33(2):108260. (PMID: 33053341)
J Neurol Sci. 1999 Jul 1;166(2):91-9. (PMID: 10475101)
J Am Heart Assoc. 2017 Jun 1;6(6):. (PMID: 28572280)
NMR Biomed. 1999 Dec;12(8):525-34. (PMID: 10668045)
Stroke. 2006 Oct;37(10):2593-600. (PMID: 16946164)
J Cereb Blood Flow Metab. 2012 Aug;32(8):1496-507. (PMID: 22491156)
Lancet. 1966 Nov 19;2(7473):1113-5. (PMID: 4162534)
J Cereb Blood Flow Metab. 2018 Dec;38(12):2192-2208. (PMID: 30009645)
Transl Stroke Res. 2016 Oct;7(5):358-67. (PMID: 27534542)
J Cereb Blood Flow Metab. 2021 Feb;41(2):253-266. (PMID: 32960688)
Stroke. 2014 Apr;45(4):1018-23. (PMID: 24595591)
J Neuroimaging. 2013 Jul;23(3):391-6. (PMID: 22913629)
Magn Reson Med. 2002 Jan;47(1):97-104. (PMID: 11754448)
J Stroke Cerebrovasc Dis. 2019 May;28(5):1212-1218. (PMID: 30704865)
Transl Stroke Res. 2017 Feb;8(1):22-32. (PMID: 27578048)
Neurology. 2022 Feb 22;98(8):e790-e801. (PMID: 34906976)
Stroke. 2016 Jan;47(1):94-8. (PMID: 26604248)
Stroke. 2020 Mar;51(3):1017-1024. (PMID: 32008460)
J Nucl Med. 2000 Aug;41(8):1409-16. (PMID: 10945535)
Stroke. 2011 Mar;42(3):693-9. (PMID: 21233472)
J Neurointerv Surg. 2023 Sep;15(e1):e26-e32. (PMID: 35701108)
J Cereb Blood Flow Metab. 2015 Feb;35(2):277-84. (PMID: 25407273)
Stroke. 2018 Jul;49(7):1796-1802. (PMID: 29760275)
Int J Mol Sci. 2017 Dec 09;18(12):. (PMID: 29232823)
J Cereb Blood Flow Metab. 2014 Dec;34(12):1944-50. (PMID: 25269516)
JAMA Neurol. 2019 Feb 1;76(2):194-202. (PMID: 30615038)
J Cereb Blood Flow Metab. 2018 Sep;38(9):1500-1516. (PMID: 28345479)
Mayo Clin Proc. 1981 Sep;56(9):533-43. (PMID: 7266064)
Neuroimaging Clin N Am. 2011 May;21(2):259-83, x. (PMID: 21640299)
J Cereb Blood Flow Metab. 2022 Mar;42(3):430-453. (PMID: 34515547)
J Magn Reson Imaging. 2021 Jun;53(6):1815-1822. (PMID: 33300253)
Stroke. 2014 May;45(5):1510-8. (PMID: 24652307)
Stroke. 2014 Apr;45(4):1035-9. (PMID: 24569816)
معلومات مُعتمدة: CVON2015-01 Dutch Heart Foundation; HA2015.01.06 Brain Foundation, Netherlands; LSHM17016 Ministerie van Economische Zaken
فهرسة مساهمة: Keywords: Acute ischemic stroke; Hyperperfusion; Hypoperfusion; Perfusion deficit; Recanalization; Reperfusion
تواريخ الأحداث: Date Created: 20230118 Date Completed: 20240119 Latest Revision: 20240305
رمز التحديث: 20240305
مُعرف محوري في PubMed: PMC10796479
DOI: 10.1007/s12975-022-01120-6
PMID: 36653525
قاعدة البيانات: MEDLINE
الوصف
تدمد:1868-601X
DOI:10.1007/s12975-022-01120-6